154 related articles for article (PubMed ID: 2121889)
1. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection.
Karupiah G; Blanden RV; Ramshaw IA
J Exp Med; 1990 Nov; 172(5):1495-503. PubMed ID: 2121889
[TBL] [Abstract][Full Text] [Related]
2. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.
Karupiah G; Coupar BE; Andrew ME; Boyle DB; Phillips SM; Müllbacher A; Blanden RV; Ramshaw IA
J Immunol; 1990 Jan; 144(1):290-8. PubMed ID: 2295796
[TBL] [Abstract][Full Text] [Related]
3. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice.
Karupiah G; Woodhams CE; Blanden RV; Ramshaw IA
J Immunol; 1991 Dec; 147(12):4327-32. PubMed ID: 1684375
[TBL] [Abstract][Full Text] [Related]
4. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism.
Foong YY; Jans DA; Rolph MS; Gahan ME; Mahalingam S
Virology; 2009 Oct; 393(2):228-37. PubMed ID: 19729181
[TBL] [Abstract][Full Text] [Related]
6. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.
Mahalingam S; Farber JM; Karupiah G
J Virol; 1999 Feb; 73(2):1479-91. PubMed ID: 9882354
[TBL] [Abstract][Full Text] [Related]
7. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma.
Kohonen-Corish MR; King NJ; Woodhams CE; Ramshaw IA
Eur J Immunol; 1990 Jan; 20(1):157-61. PubMed ID: 2106440
[TBL] [Abstract][Full Text] [Related]
8. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
Orange JS; Wang B; Terhorst C; Biron CA
J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
[TBL] [Abstract][Full Text] [Related]
9. Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice.
Perera LP; Goldman CK; Waldmann TA
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5146-51. PubMed ID: 11296252
[TBL] [Abstract][Full Text] [Related]
10. Anti-asialo-GM1 inhibits vaccinia virus infection of murine ovaries: asialo-GM1 as an additional virus receptor?
Karupiah G; Blanden RV
Immunol Cell Biol; 1990 Oct; 68 ( Pt 5)():343-6. PubMed ID: 2083955
[TBL] [Abstract][Full Text] [Related]
11. Recombinant vaccine vector-induced protection of athymic, nude mice from influenza A virus infection. Analysis of protective mechanisms.
Karupiah G; Ramsay AJ; Ramshaw IA; Blanden RV
Scand J Immunol; 1992 Jul; 36(1):99-105. PubMed ID: 1615287
[TBL] [Abstract][Full Text] [Related]
12. In vivo activation of murine natural killer cell functions by human recombinant DNA interleukin 2.
Sayers T; Rossiter H; Chung J; Hren A; Armerding D
Immunobiology; 1985 Apr; 169(3):303-18. PubMed ID: 3922876
[TBL] [Abstract][Full Text] [Related]
13. Thy 1+ asialo GM1+ dendritic epidermal cells in skin defense mechanisms of vaccinia virus-infected mice.
Ikeda S; Tominaga T; Nishimura C
Arch Virol; 1991; 117(3-4):207-18. PubMed ID: 1826826
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model.
Chen B; Timiryasova TM; Andres ML; Kajioka EH; Dutta-Roy R; Gridley DS; Fodor I
Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286
[TBL] [Abstract][Full Text] [Related]
15. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma.
Liu G; Zhai Q; Schaffner DJ; Wu A; Yohannes A; Robinson TM; Maland M; Wells J; Voss TG; Bailey C; Alibek K
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):201-6. PubMed ID: 15039095
[TBL] [Abstract][Full Text] [Related]
16. Clearance of recombinant vaccinia virus expressing IL-2: role of local host immune responses.
Hügin AW; Flexner C; Moss B
Cell Immunol; 1993 Dec; 152(2):499-509. PubMed ID: 8258152
[TBL] [Abstract][Full Text] [Related]
17. The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.
Symons JA; Adams E; Tscharke DC; Reading PC; Waldmann H; Smith GL
J Gen Virol; 2002 Nov; 83(Pt 11):2833-2844. PubMed ID: 12388820
[TBL] [Abstract][Full Text] [Related]
18. Sex-dependent, early cytokine production by NK-like spleen cells following infection with the D variant of encephalomyocarditis virus (EMCV-D).
McFarland HI; Bigley NJ
Viral Immunol; 1989; 2(3):205-14. PubMed ID: 2560916
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.
Reading PC; Smith GL
J Virol; 2003 Sep; 77(18):9960-8. PubMed ID: 12941906
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy.
Chen B; Timiryasova TM; Gridley DS; Andres ML; Dutta-Roy R; Fodor I
Cytokine; 2001 Sep; 15(6):305-14. PubMed ID: 11594797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
